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Apical splenic nerve electrical stimulation discloses an antiinflammatory pathway relying on adrenergic and nicotinic receptors in myeloid cells
. Experimental studies in rodents have shown that sympathetic nerve terminals in the spleen are able to store and release norepinephrine in response to stimulation 8, 9 , and that the splenic norepinephrine content dramatically decreased following chemical 10 or surgical 11 sympathectomy.
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Further experiment from the Tracey's group demonstrated that the splenic nerve was a critical component of the vagal anti-inflammatory pathway, a physiological regulatory mechanism whereby afferent vagus nerve stimulation by pathogen-derived products leads to efferent vagus nerve-mediated suppression of proinflammatory cytokine production by spleen macrophages in the red pulp and the marginal zone 12 . This was elegantly demonstrated by the surgical ablation of the splenic nerve which abolished the inhibition of LPS-induced TNF production by vagus nerve stimulation in mice. The vagal anti-inflammatory pathway relies on the production of norepinephrine by splenic catecholaminergic fibers 12 , which triggers the release of acetylcholine by CD4 + T cells 13 via 2 adrenergic receptors (2-AR) 14 .
Acetylcholine then binds to the α7 nicotinic acetylcholine receptors (α7nAChR) on myeloid cells resulting in the inhibition of LPS-mediated production of proinflammatory cytokines 15 . In apparent contrast to the mechanism described above, an anatomical and functional connection between the vagus and the splenic nerve could not be demonstrated by injecting anterograde tracers in the dorsal motor nucleus (DMV) of the vagus, and retrograde tracers in the spleen 16, 17 . Furthermore, action potentials in the splenic nerve could not be detected in rats following vagal electrical stimulation 16 .
Whereas the presence of catecholaminergic fibers in the spleen is well established, the presence of cholinergic fibers has been debated for many years 18, 19, 20, 21, 22, 23 , in part due to the various technical limitations that make the visualization of cholinergic structures by histochemical means challenging. While cholinergic markers have been widely used as an attempt to label cells, axons, and terminals in peripheral tissues, their lack of sensitivity has repeatedly been noted.
Furthermore, immunostaining of cholinergic markers in spleen has been described as
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highly non-specific and variable by many investigators 1, 24, 25 . While some of the data described above may appear contradictory, it should be noted that several nerve-like structures project to the spleen in rodents.
Unfortunately, most authors have referred to "the splenic nerve" in their publications without specifying the branch (or branches) that they were studying. Such an issue may be particularly problematic in experiments in which the function of the nerve fibers that project to the spleen was investigated by electrical stimulation or surgical ablation. This prompted us to perform an exhaustive anatomical and functional analysis of the nerves that project to the spleen in mice.
Results
Gross anatomy of spleen revealed three nerve-like structures among which two were associated with arteries as demonstrated by laser speckle imaging (Supp. Fig. 1, Fig. 1a ). The two arterial nerves subdivided into two branches each and entered the spleen at non-apical locations (Fig. 1a) . The third nerve referred to hereafter as the "apical splenic nerve" was not associated with an artery and entered the spleen at its apex (Fig. 1a) . Both arterial and apical nerves were
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catecholaminergic as demonstrated by immunostaining. In contrast, the apical nerve but not the arterial nerves contained cholinergic fibers (Fig. 1b) . Light sheet imaging of whole clarified spleen showed a dense network of catecholaminergic fibers across the entire spleen, and cholinergic fibers mainly located at the apex (Fig. 1c, d ). In agreement with immunostaining data, stimulation of either the apical nerve or one of the two arterial nerves increased norepinephrine levels in spleen (5.82 ± 0.2 ng/mg unstimulated; 9.64 ± 0.76 ng/mg for vagus nerve stimulation; 10.3 ± 1.89 ng/mg for the arterial nerve; 10.9 ± 1.1 ng/mg for the apical nerve) (Fig. 1e) . In contrast, only apical nerve stimulation induced the release of acetylcholine spleen (21.8 ± 3.1 µg/mg unstimulated; 38.8 ± 4.9 ng/mg for the arterial nerve; 73.4 ± 11.9 ng/mg for the apical nerve) in lymphocyte-deficient mice (Rag1 -/-) ( Fig. 1f) further suggesting that cholinergic fibers, and not T cells, were the source of acetylcholine in these experiments.
We next investigated whether electrostimulation of the apical and arterial nerves could inhibit TNF production induced by lipopolysaccharide (LPS) injection in freely moving mice. We implanted mice with electrodes on intact apical, arterial or vagus (as a control) nerves, and applied electrostimulation one week later to stimulate both afferent and efferent fibers. We first checked that electrode implantation had no effect on LPS-induced TNF production (Supp. Fig. 3 ). All nerves were equally efficient at inhibiting LPS-induced TNF release when stimulated with the same electrical parameters (53.6 ± 8.5 % for VN, 42.7 ± 6.7 % for the arterial nerve, 49.2 ± 2.9 % for the apical nerve) (Fig. 2a) . However, and at variance with vagus nerve stimulation, neither arterial nor apical nerve stimulation caused changes in arterial blood pressure or heart rate ( Fig. 2b, 2c, Supp. Fig 2) . Therefore, both
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arterial and apical splenic nerve stimulation triggered an anti-inflammatory pathway without appreciable cardiovascular off-target effects.
Because the vagal anti-inflammatory pathway was shown to be dependent on CD4 + T cells 13 , we investigated the role of these cells in the inhibition of inflammation by apical and arterial spleen nerve stimulation. As expected 13 , the inhibition of LPSinduced TNF production by vagus nerve stimulation was abolished in T cell-deficient
) mice (Fig. 2d) . This was also the case following arterial nerve stimulation (Fig. 2d) . In striking contrast, the inhibition of LPS-induced TNF production by apical nerve stimulation was not abolished in Foxn1 -/-mice (3060 ± 380 pg/ml for SHAM vs. 1724 ± 192 pg/ml for the apical nerve) demonstrating that T cells
were not required. Thus, the anti-inflammatory effects of arterial and apical splenic nerve stimulation are mediated by distinct mechanisms. This prompted us to further investigate how apical nerve stimulation inhibited LPS-induced TNF secretion.
The inhibition of LPS-induced TNF production by apical nerve stimulation was abolished by both propranolol and methyllycaconitine (MLA), but not by atropine further suggesting that  1 / 2 -ARs and α7nAchRs, but not muscarinic AchRs were involved (Fig. 3a) . Of note, a complete restoration of TNF production was achieved only when propranolol and MLA were administrated together suggesting the existence of two signaling pathways acting in parallel (Fig. 3a) . TNF production was partially restored in Adrb2 -/-further confirming a role for  2 -ARs in the antiinflammatory effects of apical nerve stimulation (Fig. 3b) .
Since the inhibition of LPS-induced TNF production by apical nerve stimulation did not require lymphocytes, we made the hypothesis that norepinephrine and acetylcholine acted directly on myeloid cells. To test this, we used LysM-Cre:Adrb2
and LysM-Cre:Chrna7 fl/fl mice in which myeloid cells 27 are selectively deficient in 2-
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ARs and α7nAchRs respectively. While apical nerve stimulation did reduce LPS- While the vagus anti-inflammatory pathway was first identified in rodents injected with LPS, vagus nerve stimulation (VNS) was eventually shown to ameliorates collagen-induced arthritis (CIA) development in rats 28 . Promising effects have also been reported in patients with Rheumatoid arthritis (RA) 29 . Because apical nerve stimulation was as efficient as VNS at inhibiting LPS-induced TNF production, we investigated whether apical splenic nerve could also inhibit CIA in arthritis-prone DBA mice. Mice were immunized with collagen II on day 0, and implanted with electrodes applied onto the apical nerve on day 11. At day 21, animals were boosted with collagen II and followed for clinical symptoms until 35 days (Fig. 4a) . Electrical stimulation was conducted every 4 hours starting on day 16. Surgical implantation of
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electrodes onto the apical splenic nerve neither modified disease incidence nor progression compared to non-operated animals (Supp. Fig. 4 ). While all SHAM mice developed arthritis within 28 days, disease onset was significantly delayed in stimulated animals, 16% of which showing complete protection throughout the study period ( Fig. 4b) . Apical nerve stimulation reduced disease severity (Fig. 4c, d ) and joint swelling (Fig. 4e) . This was accompanied by a reduction in synovial inflammation in the hind paw and reduction in tibiotalar and tarsus bone erosions in stimulated compared to SHAM mice. (Fig. 4f, g ). Further, both the frequency and numbers of inflammatory monocytes were markedly reduced in the spleen of stimulated animals ( Fig. 4h, i) . Altogether, our results demonstrate that apical nerve stimulation inhibited CIA in mice.
Discussion
In this study, we have performed an exhaustive anatomical and functional analysis of the neural fibers that project to the spleen in mice. As expected, we found that the vast majority of the neural fibers that are present in the spleen are catecholaminergic as demonstrated by TH immunostaining. These fibers originated from at least three nerve branches among which two run along splenic arteries and one does not. This third nerve branch, which entered the spleen at its apex, has already been described but the nature of the fibers that it contains was not investigated 30, 17 . While the origin of the cholinergic apical fibers is not known, they are likely to originate from either a vagus branch or the splanchnic (supra-renal ganglion). In agreement with immunostaining data, we found that electrical stimulation of any of these three nerve branches induced the release of norepinephrine in the spleen.
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In addition to catecholaminergic fibers, we found that the apical nerve, but not the two arterial nerves, also contained cholinergic fibers as demonstrated by ChAT immunostaining. While some authors have already reported the presence of ChATpositive neural fibers in the spleen, these findings have been debated for years in part due to the relatively low sensitivity and selectivity of ChAT immunostaining reagents and procedures. In agreement with our immunostaining data, we found that stimulation of the apical nerve, but not of the arterial nerves, increased acetylcholine spleen content. This latter phenomenon was observed in both immunocompetent and T lymphocyte-deficient mice, further suggesting that neural fibers, and not other acetylcholine producing cells, were the source of acetylcholine in these experiments.
Pioneer studies by Tracey's group has demonstrated the existence of a vagus anti-inflammatory reflex in which signals traveling in the vagus nerve modulate the activity of the splenic nerve, which secretes norepinephrine in spleen. In agreement with these data, stimulation of either the vagus nerve or one of the two arterial splenic nerve inhibited LPS-induced inflammation, and this phenomenon was abolished in T cell-deficient nude (Foxn1 -/-) mice. In striking contrast, the inhibition of LPS-induced TNF production by apical nerve stimulation was neither abolished in Foxn1 -/-mice, nor in RAG-2 -/-mice that lack both T and B lymphocytes. Therefore, while apical and arterial splenic nerve stimulation were equally efficient at inhibiting LPS-induced secretion, they relied on different underlying mechanisms. We propose to refer to this newly described pathway as "apical splenic anti-inflammatory pathway", which co-exists with the previously described vagal anti-inflammatory pathway. In contrast to the vagal anti-inflammatory pathway 31 , the apical splenic anti-inflammatory pathway does not require the presence of T cells and is dependent on 2-ARs signaling in myeloid cells. While the apical splenic and the vagal anti-
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inflammatory pathways are both dependent on α7nAchRs signaling in myeloid cells, the former relies on the 2-ARs and α7nAchRs pathways acting in parallel while the later relies on these pathways acting sequentially (Fig. 5) . Another important difference between the vagal anti-inflammatory pathway and the new apical splenic anti-inflammatory pathway is that the former impacts a variety of organs 32 including the gastrointestinal tract 33 and the kidneys 34 while the latter targets the spleen only. It remains to be determined whether other vagus-unrelated peripheral nerves could convey an anti-inflammatory signal to specific tissues, and more specifically to organdraining lymph nodes.
RA is a chronic degenerative autoimmune disease characterized by joint synovial inflammation and bone cartilage erosion leading to significant disabilities 35 .
While symptomatic relief can be achieved by treatment with anti-TNF antibodies and other biologicals, a sizeable proportion of RA patients do not respond to these . While VNS is currently approved for the treatment of drug resistant epilepsy and depression with no major side-effects, it sometimes carries the risks of untoward off-target effects depending on the electrostimulation parameters and the sensitivity of the patient 37 . VNS produced heart rate reductions in most preclinical species involving rodents as well as large animals 38, 39 . However electrostimulation of apical splenic nerve is not associated with significant impact on cardiovascular parameters in mice in accordance with the absence of detectable afferent fibers in this nerve. Thus, at variance with vagus nerve stimulation, apical nerve stimulation may offer the opportunity to deliver a boarder panel of electrical parameters of
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stimulation that may improve therapeutic efficacy. While it remains to be determined whether apical splenic nerve stimulation is as efficient as VNS at inhibiting CIA, stimulating the splenic nerve instead of the vagus nerve might offers an alternative for RA patients. On another topic, the mechanisms underlying the beneficial impact of apical splenic nerve stimulation on CIA remain to be identified. Based on our data in the LPS model, we could hypothesize that it involves the 2-ARs and α7nAchRs
pathways acting in parallel in myeloid cells to inhibit the secretion of pro-inflammatory cytokines. Whatever the case, other mechanisms may also be at play including the mobilization of regulatory T cells.
These results pave the way for the use of splenic nerve electrical stimulation as a promising alternative to other therapeutic strategies in RA with less side effects.
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Supplemental figure 2: Impact of vagus and apical nerve electrical stimulation on carotid blood pressure and heart rate in anesthetized mice before and after initiation of electrical stimulation. C57/BL6 mice were anesthetized and a catheter was introduced into the carotid and connected to a pressure transducer for blood pressure and heart rate recordings. A tunnel or a sling cuff electrode was placed on the vagus or apical splenic nerve respectively and different patent of stimulation were delivered starting by the lowest intensity. Data show representative measurement in on mice out of 4. Baseline mean values were 432 ± 42.7 beats/minutes and 85 ± 8 mm Hg for heart rate and blood pressure respectively. (blancou@ipmc.cnrs.fr).
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Online Methods:
Mice: C57BL/6, DBA, Foxn1 were implanted onto the vagus nerve.
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Electrostimulation: Mice were anesthetized and either 100 µm sling or 200 µm tunnel Cortec electrodes were implanted onto the splenic nerves (apical or arterial) or the vagus nerve respectively. Seven days following surgery, these animals were injected ip with a sublethal dose of LPS (5 mg/kg) which has been used in previous studies to induce LPS production 40 . Electrostimulation was applied using a PlexStim V2.3 (Plexon) starting at -10, 0 and +20 minutes relative to LPS injection. Sera was collected at 90 minutes after LPS injection and assessed for TNF levels. Controls consist of fully Cortec implanted mice, which did not receive electrical stimulation (SHAM). Electrostimulation were rectangular charged-balanced biphasic pulses with 650 µA pulse amplitude, 100 µs pulse width (positive and negative) at 10 Hz frequency for 2 minutes (STIM).
Carotid blood pressure: C57/BL6 mice were anaesthetized as described above, a catheter was placed into the left carotid, connected to a pressure transducer and recorded using a Acqknowledge 881 (MP100WS) software (Biopac System, Inc). A tunnel or cuff electrode were placed under the vagus nerve or the splenic respectively and different patent of stimulation were delivered starting by the lowest instensity. Mean blood pressure and heart rate were analyses using Biopac data acquisition Acqknowledge 881 (MP100WS) software (Biopac System, Inc). Chondrex). DBA mice were immunized intradermally at the base of the tail with 100 μl of emulsion (100 μg collagen) on day 0 and day 21. At day 11, mice were anaesthetized with isoflurane and the spleen area was exposed. One mm length 100 µm-sling micro-cuff electrode (CorTec) was implanted onto the apical splenic nerve.
At day 16, mice were placed in individual cage and connected to a PlexStim V2. Statistics: CIA progression was plotted using Kaplan-Meier's curves and differences between groups were estimated using the log-rank test. Normality of sample distribution was assessed using the Kolmogorov-Smirnov test. For comparison between two groups, statistical significance was assessed using unpaired t-test. For comparison between more than two groups, statistical significance was assessed using one-way ANOVA followed by Tukey's post hoc test. All statistical analysis were performed using GraphPad Prism v.6.
